{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:26:34Z","timestamp":1794565594151,"version":"4.9.1"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014849","name":"Valencia Department of Education Culture and Sport","doi-asserted-by":"publisher","award":["CIAICO\/2023\/137"],"award-info":[{"award-number":["CIAICO\/2023\/137"]}],"id":[{"id":"10.13039\/501100014849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neubiorev.2026.106727","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:20:08Z","timestamp":1778084408000},"page":"106727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Multimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS"],"prefix":"10.1016","volume":"187","author":[{"given":"Rafael","family":"L\u00f3pez-Blanch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Oriol-Caballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Estrela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Obrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2026.106727_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1148\/radiol.2018180112","article-title":"Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis","volume":"289","author":"Acosta-Cabronero","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3390\/cells12131763","article-title":"Recent advances in extracellular vesicles in amyotrophic lateral sclerosis and emergent perspectives","volume":"12","author":"Afonso","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2026.106727_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/011570159X342720241014164650","article-title":"Oxidative stress-mediated lipid peroxidation-derived lipid aldehydes in the pathophysiology of neurodegenerative diseases","volume":"23","author":"Allowitz","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib5","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1212\/WNL.0000000000003427","article-title":"Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis","volume":"87","author":"Alshikho","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92112-3","article-title":"Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders","volume":"11","author":"Area-Gomez","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106727_bib7","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1093\/brain\/awae109","article-title":"Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial","volume":"147","author":"Babu","year":"2024","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102648","article-title":"Ultra-high field (7T) functional magnetic resonance imaging in amyotrophic lateral sclerosis: a pilot study","volume":"30","author":"Barry","year":"2021","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neubiorev.2026.106727_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41593-021-01006-0","article-title":"Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines","volume":"25","author":"Baxi","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ana.410420416","article-title":"Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis","volume":"42","author":"Beal","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib11","first-page":"298","article-title":"Investigation of ongoing denervation and reinnervation in amyotrophic lateral sclerosis by using concentric needle electrode with single fiber electromyography method","volume":"60","author":"Bekdik","year":"2023","journal-title":"Noro Psikiyatr. Arsivi"},{"key":"10.1016\/j.neubiorev.2026.106727_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105323","article-title":"Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis","volume":"108","author":"Benatar","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neubiorev.2026.106727_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.26860","article-title":"Biomarker qualification for neurofilament light chain in amyotrophic lateral sclerosis: theory and practice","volume":"95","author":"Benatar","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(24)00479-4","article-title":"Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention","volume":"24","author":"Benatar","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib15","first-page":"1248","article-title":"Design of a randomized, placebo-controlled, phase 3 trial of tofersen initiated in clinically presymptomatic SOD1 variant carriers: the ATLAS study","volume":"19","author":"Benatar","year":"2022","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.neubiorev.2026.106727_bib16","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.0b013e31826e9b1d","article-title":"Presymptomatic studies in ALS: rationale, challenges, and approach","volume":"79","author":"Benatar","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib17","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib18","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1021\/acs.jproteome.0c00216","article-title":"Metabolite profiling reveals predictive biomarkers and the absence of \u03b2-Methyl amino-l-alanine in plasma from individuals diagnosed with amyotrophic lateral sclerosis","volume":"19","author":"Bereman","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.neubiorev.2026.106727_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17389-9","article-title":"Lipidomics reveals cerebrospinal-fluid signatures of ALS","volume":"7","author":"Blasco","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106727_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0891-5849(00)00349-X","article-title":"Increased oxidative damage to DNA in ALS patients","volume":"29","author":"Bogdanov","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(00)00365-8","article-title":"Blood oxidative stress in amyotrophic lateral sclerosis","volume":"178","author":"Bonnefont-Rousselot","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib23","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1080\/15548627.2024.2358736","article-title":"Poly-GP accumulation due to C9orf72 loss of function induces motor neuron apoptosis through autophagy and mitophagy defects","volume":"20","author":"de Calbiac","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.neubiorev.2026.106727_bib24","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/brainsci14080760","article-title":"Physiological biomarkers of upper motor neuron dysfunction in ALS","volume":"14","author":"Calma","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib25","first-page":"294","article-title":"Electrodiagnosis of amyotrophic lateral sclerosis: a review of existing guidelines","volume":"37","author":"de Carvalho","year":"2020","journal-title":"J. Clin. Neurophysiol. Off. Publ. Am. Electroencephalogr. Soc."},{"key":"10.1016\/j.neubiorev.2026.106727_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ncrna.2024.02.006","article-title":"Systematic review and meta-analysis of dysregulated microRNAs derived from liquid biopsies as biomarkers for amyotrophic lateral sclerosis","volume":"9","author":"Casado Gama","year":"2024","journal-title":"Non-Coding RNA Res"},{"key":"10.1016\/j.neubiorev.2026.106727_bib27","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1093\/brain\/awad075","article-title":"Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis","volume":"146","author":"Catanese","year":"2023","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib28","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","article-title":"Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS","volume":"30","author":"Chatterjee","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib29","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1158\/1078-0432.CCR-07-4535","article-title":"Validation of analytic methods for biomarkers used in drug development","volume":"14","author":"Chau","year":"2008","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.neubiorev.2026.106727_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fnins.2019.00574","article-title":"Increased Interleukin-6 Levels in the Astrocyte-Derived Exosomes of Sporadic Amyotrophic Lateral Sclerosis Patients","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40035-020-00228-9","article-title":"Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"10","author":"Cheng","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib32","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/s41591-025-03890-6","article-title":"A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis","volume":"31","author":"Chia","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13000-024-01473-6","article-title":"Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review","volume":"19","author":"Darabi","year":"2024","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"De Schaepdryver","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106727_bib35","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.clinph.2020.06.019","article-title":"Motor unit number index as an individual biomarker: Reference limits of intra-individual variability over time in healthy subjects","volume":"131","author":"Delmont","year":"2020","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/21678421.2019.1606244","article-title":"The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public","volume":"20","author":"van der Spek","year":"2019","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib37","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1038\/s41598-019-39739-5","article-title":"A ferroptosis\u2013based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis","volume":"9","author":"Devos","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106727_bib38","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1038\/s41598-017-10161-z","article-title":"Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients","volume":"7","author":"Di Pietro","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106727_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41420-020-00397-6","article-title":"A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients","volume":"7","author":"Dobrowolny","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.neubiorev.2026.106727_bib40","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3390\/brainsci14121251","article-title":"Neurophysiologic Innovations in ALS: enhancing Diagnosis, Monitoring, and Treatment Evaluation","volume":"14","author":"Donaghy","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib41","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neubiorev.2026.106727_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41467-022-35494-w","article-title":"Molecular subtypes of ALS are associated with differences in patient prognosis","volume":"14","author":"Eshima","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib43","article-title":"Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries","volume":"13","author":"Falc\u00e3o de Campos","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101700","article-title":"Ubiquitin homeostasis is disrupted in TDP-43 and FUS cell models of ALS","volume":"23","author":"Farrawell","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.neubiorev.2026.106727_bib45","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neubiorev.2026.106727_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cca.2015.05.024","article-title":"Pre-analytical and analytical factors influencing Alzheimer\u2019s disease cerebrospinal fluid biomarker variability","volume":"449","author":"Fourier","year":"2015","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.neubiorev.2026.106727_bib47","first-page":"1180","article-title":"Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design","volume":"19","author":"Fournier","year":"2022","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.neubiorev.2026.106727_bib48","first-page":"2325","article-title":"Transcriptomic profiling of cerebrospinal fluid identifies ALS pathway enrichment and RNA biomarkers in MND individuals","volume":"248","author":"Fr\u00f6hlich","year":"2023","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib49","first-page":"564","article-title":"The motor unit number index of subclinical abnormality in amyotrophic lateral sclerosis","volume":"33","author":"Fukada","year":"2016","journal-title":"J. Clin. Neurophysiol. Off. Publ. Am. Electroencephalogr. Soc."},{"key":"10.1016\/j.neubiorev.2026.106727_bib50","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/acn3.51035","article-title":"Evolution of white matter damage in amyotrophic lateral sclerosis","volume":"7","author":"Gabel","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2017.11.017","article-title":"Diffusion tensor imaging identifies presymptomatic axonal degeneration in the spinal cord of ALS mice","volume":"1679","author":"Gatto","year":"2018","journal-title":"Brain Res"},{"key":"10.1016\/j.neubiorev.2026.106727_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00377","article-title":"The chitinases as biomarkers for amyotrophic lateral sclerosis: signals from the CNS and beyond","volume":"11","author":"Gaur","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib53","first-page":"2404","article-title":"ADDENDUM: genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors","volume":"21","author":"Goldman","year":"2019","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.neubiorev.2026.106727_bib54","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41467-021-22098-z","article-title":"A conserved role for the ALS-linked splicing factor SFPQ in repression of pathogenic cryptic last exons","volume":"12","author":"Gordon","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of ALS","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41582-023-00867-2","article-title":"The amyotrophic lateral sclerosis exposome: recent advances and future directions","volume":"19","author":"Goutman","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/mus.26801","article-title":"Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS","volume":"62","author":"Goyal","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neubiorev.2026.106727_bib58","article-title":"A multi-center study of neurofilament assay reliability and inter-laboratory variability","volume":"21","author":"Gray","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2377-6-17","article-title":"Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis","volume":"6","author":"Grosskreutz","year":"2006","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135488","article-title":"Use of CMAP, MScan fit-MUNE, and MUNIX in understanding neurodegeneration pattern of ALS and detection of early motor neuron loss in daily practice","volume":"741","author":"Gunes","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2026.106727_bib61","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nsmb.2053","article-title":"An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity","volume":"18","author":"Guo","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.637","article-title":"Evaluating the levels of CSF and serum factors in ALS","volume":"7","author":"Guo","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.neubiorev.2026.106727_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2025.102809","article-title":"Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice","volume":"252","author":"Haidar","year":"2025","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib64","doi-asserted-by":"crossref","first-page":"w14192","DOI":"10.4414\/smw.2015.14192","article-title":"New and emerging roles of small RNAs in neurodegeneration, muscle, cardiovascular and inflammatory diseases","volume":"145","author":"Hruska-Plochan","year":"2015","journal-title":"Swiss Med. Wkly"},{"key":"10.1016\/j.neubiorev.2026.106727_bib65","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acn3.51078","article-title":"Longitudinal biomarkers in amyotrophic lateral sclerosis","volume":"7","author":"Huang","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib66","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/acn3.51697","article-title":"Identification of potential pathways and biomarkers linked to progression in ALS","volume":"10","author":"Huber","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib67","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2169\/internalmedicine.51.7465","article-title":"Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study","volume":"51","author":"Ikeda","year":"2012","journal-title":"Intern. Med. Tokyo Jpn"},{"key":"10.1016\/j.neubiorev.2026.106727_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2026.106727_bib69","doi-asserted-by":"crossref","first-page":"e1619","DOI":"10.1212\/WNL.0000000000006383","article-title":"CSF sAPP\u03b2, YKL-40, and NfL along the ALS-FTD spectrum","volume":"91","author":"Ill\u00e1n-Gala","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib70","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1038\/s41591-025-03834-0","article-title":"The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging","volume":"31","author":"Imam","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","article-title":"A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD","volume":"30","author":"Irwin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","article-title":"Fluid biomarkers for amyotrophic lateral sclerosis: a review","volume":"19","author":"Irwin","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib73","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41598-025-30022-4","article-title":"Correlation analysis of serum neurofilament light chain and glial fibrillary acidic protein levels with amyotrophic lateral sclerosis","volume":"16","author":"Ji","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106727_bib74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s40142-017-0123-8","article-title":"Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and opportunities","volume":"5","author":"Joardar","year":"2017","journal-title":"Curr. Genet. Med. Rep."},{"key":"10.1016\/j.neubiorev.2026.106727_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41746-023-00778-y","article-title":"Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures","volume":"6","author":"Johnson","year":"2023","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib76","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2015.05.027","article-title":"4-Hydroxynonenal induces persistent insolubilization of TDP-43 and alters its intracellular localization","volume":"463","author":"Kabuta","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib77","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1212\/WNL.0000000000010235","article-title":"A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS","volume":"95","author":"Kalra","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib78","first-page":"136","article-title":"Corticospinal tract degeneration and possible pathogenesis in ALS evaluated by MR diffusion tensor imaging","volume":"5","author":"Karlsborg","year":"2004","journal-title":"Amyotroph. Lateral Scler. Mot. Neuron Disord. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis."},{"key":"10.1016\/j.neubiorev.2026.106727_bib79","first-page":"790","article-title":"Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS\/FTLD","volume":"26","author":"Khosravi","year":"2017","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neubiorev.2026.106727_bib80","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41582-020-00434-z","article-title":"Improving clinical trial outcomes in amyotrophic lateral sclerosis","volume":"17","author":"Kiernan","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib81","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00415-025-13143-8","article-title":"New developments in imaging in ALS","volume":"272","author":"Kleinerova","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib82","doi-asserted-by":"crossref","first-page":"313","DOI":"10.31662\/jmaj.2024-0038","article-title":"Abnormal splicing events due to loss of nuclear function of TDP-43: pathophysiology and perspectives","volume":"7","author":"Koike","year":"2024","journal-title":"JMA J."},{"key":"10.1016\/j.neubiorev.2026.106727_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260323","article-title":"Amyotrophic lateral sclerosis: correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics","volume":"16","author":"Kojima","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.neubiorev.2026.106727_bib84","article-title":"Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures","volume":"249","author":"K\u00f5ks","year":"2024","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib85","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1093\/hmg\/ddt261","article-title":"Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice","volume":"22","author":"Koval","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neubiorev.2026.106727_bib86","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/exnr.1999.7190","article-title":"ALS-linked Cu\/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis","volume":"160","author":"Kruman","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib87","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41598-018-36873-4","article-title":"Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach","volume":"9","author":"Kueffner","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106727_bib88","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp-2015-310998","article-title":"Rate of disease progression: a prognostic biomarker in ALS","volume":"87","author":"Labra","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106727_bib89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5607\/en.2016.25.5.233","article-title":"Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS","volume":"25","author":"Lee","year":"2016","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib90","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mus.27797","article-title":"Utilizing machine learning and lipidomics to distinguish primary lateral sclerosis from amyotrophic lateral sclerosis","volume":"67","author":"Lee","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neubiorev.2026.106727_bib91","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15252\/emmm.201607486","article-title":"Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS\/FTD","volume":"9","author":"Lehmer","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac8201","article-title":"Human endogenous retrovirus-K contributes to motor neuron disease","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib93","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2174\/1568026615666150302105343","article-title":"Autophagy regulators as potential cancer therapeutic agents: a review","volume":"15","author":"Li","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neubiorev.2026.106727_bib94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","article-title":"Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS","volume":"237","author":"Liao","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib95","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12967-025-06425-2","article-title":"Machine learning and multi-omics integration: advancing cardiovascular translational research and clinical practice","volume":"23","author":"Lin","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib96","first-page":"262","article-title":"CLT-01 The NEALS Consortium - a collaborative research organization","volume":"20","author":"Lincoln","year":"2019","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib97","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.aab0983","article-title":"TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD","volume":"349","author":"Ling","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2026.106727_bib98","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.0022-3042.2001.00720.x","article-title":"Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival","volume":"80","author":"Liu","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2026.106727_bib99","article-title":"Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS mice","volume":"21","author":"L\u00f3pez-Blanch","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neubiorev.2026.106727_bib100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","article-title":"TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106727_bib101","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/hmg\/ddaf111","article-title":"Familial ALS\/FTD-associated RNA-binding deficient TDP-43 mutants cause neuronal and synaptic transcript dysregulation in vitro","volume":"34","author":"Magarotto","year":"2025","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neubiorev.2026.106727_bib102","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41593-021-00936-z","article-title":"Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis","volume":"24","author":"Magen","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.irn.2024.04.010","article-title":"Use of biomarkers in clinical trials and future developments that will help identify novel biomarkers","volume":"176","author":"Malaspina","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib104","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s40478-023-01686-8","article-title":"Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data","volume":"11","author":"Marriott","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2021-327877","article-title":"Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis","volume":"93","author":"Masrori","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106727_bib106","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41582-023-00891-2","article-title":"Biomarkers in amyotrophic lateral sclerosis: current status and future prospects","volume":"19","author":"McMackin","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neubiorev.2026.106727_bib108","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41467-022-35724-1","article-title":"Integrative genetic analysis illuminates ALS heritability and identifies risk genes","volume":"14","author":"Megat","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib109","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS","volume":"2","author":"Menke","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib110","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib111","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/01.wnl.0000188907.97339.76","article-title":"Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?","volume":"65","author":"Moreau","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib112","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/cells12141884","article-title":"A diagnostic gene-expression signature in fibroblasts of amyotrophic lateral sclerosis","volume":"12","author":"Morello","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2026.106727_bib113","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.clinph.2016.11.026","article-title":"Motor Unit Number Index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in Amyotrophic Lateral Sclerosis","volume":"128","author":"Neuwirth","year":"2017","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38583","article-title":"Amyotrophic lateral sclerosis diagnosis using machine learning and multi-omic data integration","volume":"10","author":"Nikafshan Rad","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neubiorev.2026.106727_bib115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1743-0003-11-144","article-title":"Accelerometer measurement of upper extremity movement after stroke: a systematic review of clinical studies","volume":"11","author":"Noork\u00f5iv","year":"2014","journal-title":"J. Neuroeng. Rehabil."},{"key":"10.1016\/j.neubiorev.2026.106727_bib116","article-title":"ALS molecular subtypes are a combination of cellular, genetic, and pathological features learned by deep multiomics classifiers","author":"O\u2019Neill","year":"2024","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib117","article-title":"Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis","volume":"9","author":"Obrador","year":"2020","journal-title":"Antioxid. Basel Switz."},{"key":"10.1016\/j.neubiorev.2026.106727_bib118","article-title":"Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1G93A Mice","author":"Obrador","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib119","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.3390\/ijms22126352","article-title":"The link between oxidative stress, redox status, bioenergetics and mitochondria in the pathophysiology of ALS","volume":"22","author":"Obrador","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","article-title":"Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS","volume":"17","author":"Oeckl","year":"2016","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib121","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/biomedicines11051250","article-title":"Discovery of biomarkers for amyotrophic lateral sclerosis from human cerebrospinal fluid using mass-spectrometry-based proteomics","volume":"11","author":"Oh","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neubiorev.2026.106727_bib122","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jns.2013.10.038","article-title":"Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis","volume":"336","author":"Osborne","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib123","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clinph.2023.09.018","article-title":"Utility of split hand index with different motor unit number estimation techniques in ALS","volume":"156","author":"Pavey","year":"2023","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib124","first-page":"149","article-title":"Guidelines for genetic counselling for neurological diseases: ethical issues","volume":"102","author":"Petrini","year":"2011","journal-title":"Minerva Med"},{"key":"10.1016\/j.neubiorev.2026.106727_bib125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/ebm.2025.10600","article-title":"The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis","volume":"250","author":"Pfaff","year":"2025","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/ebm.2025.10575","article-title":"Retrotransposition-competent L1s are increased in the genomes of individuals with amyotrophic lateral sclerosis","volume":"250","author":"Pfaff","year":"2025","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib128","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac340","article-title":"Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis","volume":"5","author":"Phan","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib129","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib130","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41431-018-0177-4","article-title":"Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis","volume":"26","author":"Project MinE ALS Sequencing Consortium","year":"2018","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"10.1016\/j.neubiorev.2026.106727_bib131","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/acn3.51428","article-title":"Humoral response to neurofilaments and dipeptide repeats in ALS progression","volume":"8","author":"Puentes","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib132","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/481745","article-title":"Diffusion tensor imaging evaluation of corticospinal tract hyperintensity in upper motor neuron-predominant ALS patients","volume":"2011","author":"Rajagopalan","year":"2011","journal-title":"J. Aging Res."},{"key":"10.1016\/j.neubiorev.2026.106727_bib133","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fneur.2019.00234","article-title":"Longitudinal 18F-FDG PET and MRI reveal evolving imaging pathology that corresponds to disease progression in a patient with ALS-FTD","volume":"10","author":"Rajagopalan","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib134","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/21678421.2020.1818784","article-title":"Degeneration of gray and white matter differs between hypometabolic and hypermetabolic brain regions in a patient with ALS-FTD: a longitudinal MRI\u2009-\u2009PET multimodal study","volume":"22","author":"Rajagopalan","year":"2021","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/acschemneuro.7b00503","article-title":"Excitatory and inhibitory neuronal circuits in the spinal cord and their role in the control of motor neuron function and degeneration","volume":"9","author":"Ram\u00edrez-Jarqu\u00edn","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib136","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2026.106727_bib137","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/21678421.2014.971813","article-title":"Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States","volume":"16","author":"Rechtman","year":"2015","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.663637","article-title":"TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib139","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.3390\/jcm12155036","article-title":"Prognostic Usefulness of Motor Unit Number Index (MUNIX) in patients newly diagnosed with amyotrophic lateral sclerosis","volume":"12","author":"Risi","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(02)00357-X","article-title":"Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid","volume":"207","author":"Rizzardini","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123112","article-title":"High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS","volume":"463","author":"Ros\u00e9n","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1636303","article-title":"Biomarkers in ALS trials: from discovery to clinical utility","volume":"19","author":"Roy","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib143","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad152","article-title":"Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis","volume":"5","author":"Ruf","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib144","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2007.02.018","article-title":"Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant","volume":"256","author":"Sanelli","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib145","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa142","article-title":"TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients","volume":"2","author":"Scial\u00f2","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib146","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg7162","article-title":"Mis-spliced transcripts generate de novo proteins in TDP-43\u2013related ALS\/FTD","volume":"16","author":"Seddighi","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2026.106727_bib147","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41598-023-27863-2","article-title":"Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence","volume":"13","author":"Segura","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106727_bib148","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF03160574","article-title":"Glutamate, excitotoxicity and amyotrophic lateral sclerosis","volume":"244","author":"Shaw","year":"1997","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib149","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1212\/WNL.0000000000003741","article-title":"Urinary p75ECD: a prognostic, disease progression, and pharmacodynamic biomarker in ALS","volume":"88","author":"Shepheard","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainres.2004.05.110","article-title":"Accumulation of protein-bound 4-hydroxy-2-hexenal in spinal cords from patients with sporadic amyotrophic lateral sclerosis","volume":"1019","author":"Shibata","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neubiorev.2026.106727_bib151","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1074\/jbc.M115.713552","article-title":"Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils","volume":"291","author":"Shimonaka","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2026.106727_bib152","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clinph.2024.03.015","article-title":"Neurophysiological and imaging biomarkers of lower motor neuron dysfunction in motor neuron diseases\/amyotrophic lateral sclerosis: IFCN handbook chapter","volume":"162","author":"Shin-Yi Lin","year":"2024","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib153","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib154","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/cells13020178","article-title":"ALS\u2019 perfect storm: C9orf72-associated toxic dipeptide repeats as potential multipotent disruptors of protein homeostasis","volume":"13","author":"Smeele","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2026.106727_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102315","article-title":"Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis","volume":"27","author":"Spinelli","year":"2020","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neubiorev.2026.106727_bib156","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fneur.2018.01055","article-title":"Developing a neuroimaging biomarker for amyotrophic lateral sclerosis: multi-center data sharing and the road to a Global Cohort","volume":"9","author":"Steinbach","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib157","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-510X(99)00300-7","article-title":"Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus","volume":"173","author":"Stieber","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib158","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000614","article-title":"Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS\/TLS","volume":"9","author":"Sun","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s10038-022-01055-8","article-title":"Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy","volume":"68","author":"Suzuki","year":"2023","journal-title":"J. Hum. Genet"},{"key":"10.1016\/j.neubiorev.2026.106727_bib161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106727_bib162","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13024-025-00890-5","article-title":"Entering the era of precision medicine to treat amyotrophic lateral sclerosis","volume":"20","author":"Theunissen","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib163","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/acn3.70001","article-title":"ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression","volume":"12","author":"Thomas","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib164","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac029","article-title":"Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain","volume":"4","author":"Thompson","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2026.106727_bib166","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/cells13050452","article-title":"Unraveling the Heterogeneity of ALS-A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials","volume":"13","author":"Tzeplaeff","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2026.106727_bib167","doi-asserted-by":"crossref","first-page":"e1669","DOI":"10.1212\/WNL.0000000000006438","article-title":"Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS","volume":"91","author":"Van den Bos","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106727_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.679199","article-title":"Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"15","author":"Verde","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib169","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","article-title":"Neuromuscular junction dysfunction in amyotrophic lateral sclerosis","volume":"59","author":"Verma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib170","first-page":"164","article-title":"Utility of threshold tracking transcranial magnetic stimulation in ALS","volume":"3","author":"Vucic","year":"2018","journal-title":"Clin. Neurophysiol. Pr."},{"key":"10.1016\/j.neubiorev.2026.106727_bib171","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/B978-0-444-53497-2.00045-0","article-title":"Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology","volume":"116","author":"Vucic","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136039","article-title":"Cortical hyperexcitability: diagnostic and pathogenic biomarker of ALS","volume":"759","author":"Vucic","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2026.106727_bib173","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/jnnp-2012-304019","article-title":"Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights","volume":"84","author":"Vucic","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106727_bib174","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1038\/s44318-025-00506-0","article-title":"ALS-associated RNA-binding proteins promote UNC13A transcription through REST downregulation","volume":"44","author":"Watanabe","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.neubiorev.2026.106727_bib175","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.3390\/ijms20133161","article-title":"Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders","volume":"20","author":"Werry","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106727_bib176","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40035-021-00257-y","article-title":"Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials","volume":"10","author":"Witzel","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106727_bib177","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105753","article-title":"Linear associations between clinically assessed upper motor neuron disease and diffusion tensor imaging metrics in amyotrophic lateral sclerosis","volume":"9","author":"Woo","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.neubiorev.2026.106727_bib178","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.neuron.2023.01.010","article-title":"Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects","volume":"111","author":"Workman","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2026.106727_bib179","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s42003-025-08578-8","article-title":"Machine learning-based proteomics profiling of ALS identifies downregulation of RPS29 that maintains protein homeostasis and STMN2 level","volume":"8","author":"Xu","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neubiorev.2026.106727_bib180","article-title":"Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis","volume":"7","author":"Yildiz","year":"2025","journal-title":"Brain Commun."},{"key":"10.1016\/j.neubiorev.2026.106727_bib181","first-page":"992","article-title":"Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis","volume":"110","author":"Zhang","year":"2022"},{"key":"10.1016\/j.neubiorev.2026.106727_bib182","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41594-020-00537-7","article-title":"TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS","volume":"28","author":"Zuo","year":"2021","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426001843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426001843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:01:15Z","timestamp":1794564075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763426001843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":182,"alternative-id":["S0149763426001843"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106727","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106727"}}